Cover Image
市場調查報告書

亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE):全球臨床實驗檢討

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 318330
出版日期 內容資訊 英文 61 Pages
訂單完成後即時交付
價格
Back to Top
亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE):全球臨床實驗檢討 Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014
出版日期: 2014年10月31日 內容資訊: 英文 61 Pages
簡介

本報告提供亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Celgene Corporation
    • Astion Pharma A/S
    • Amgen Inc.
    • Rigel Pharmaceuticals, Inc.
    • Immunomedics, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Department of Health, South Africa
    • Florida Academic Dermatology Centers
    • The Newcastle upon Tyne Hospitals NHS Foundation Trust
    • Shahid Beheshti University of Medical Sciences
    • The Cleveland Clinic
    • Wake Forest University
    • New York University School of Medicine
    • National Cancer Institute
    • University of Leipzig

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2375CTIDB

GlobalData's clinical trial report, "Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014" provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Celgene Corporation
      • Clinical Trial Overview of Celgene Corporation
      • Astion Pharma A/S
      • Clinical Trial Overview of Astion Pharma A/S
      • Amgen Inc.
      • Clinical Trial Overview of Amgen Inc.
      • Rigel Pharmaceuticals, Inc.
      • Clinical Trial Overview of Rigel Pharmaceuticals, Inc.
      • Immunomedics, Inc.
      • Clinical Trial Overview of Immunomedics, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Department of Health, South Africa
      • Clinical Trial Overview of Department of Health, South Africa
      • Florida Academic Dermatology Centers
      • Clinical Trial Overview of Florida Academic Dermatology Centers
      • The Newcastle upon Tyne Hospitals NHS Foundation Trust
      • Clinical Trial Overview of The Newcastle upon Tyne Hospitals NHS Foundation Trust
      • Shahid Beheshti University of Medical Sciences
      • Clinical Trial Overview of Shahid Beheshti University of Medical Sciences
      • The Cleveland Clinic
      • Clinical Trial Overview of The Cleveland Clinic
      • Wake Forest University
      • Clinical Trial Overview of Wake Forest University
      • New York University School of Medicine
      • Clinical Trial Overview of New York University School of Medicine
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • University of Leipzig
      • Clinical Trial Overview of University of Leipzig
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Astion Pharma A/S, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Immunomedics, Inc., 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Department of Health, South Africa, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Florida Academic Dermatology Centers, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Newcastle upon Tyne Hospitals NHS Foundation Trust, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shahid Beheshti University of Medical Sciences, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by The Cleveland Clinic, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2014*

List of Figures

  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top